Skip to main content
Livermore
Livermore
ZHEN

Jain Global LLC

SEC CIK
0002024579
Latest filing
Aug 14, 2026

The latest 13F from Jain Global LLC covers Q2 2026 (filed Aug 14, 2026): 1,417 long positions worth $8.49B. The top 10 holdings make up 19.1% of the portfolio, and the largest is SPDR S&P 500 ETF Trust (SPY) at 3.7%. Livermore has 7 filings on Form 13F from this institution, going back to Q4 2024.

What changed in Q2 2026

Share counts compared with Q1 2026: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.

Full comparison
New
908
Est. +$3.08B
Added
256
Est. +$1.68B
Reduced
213
Est. −$2.58B
Sold out
404
Est. −$2.38B

Top 5 holdings

Share of this quarter's portfolio value

  1. SPYSPDR S&P 500 ETF Trust
    3.7%$315.2MHistory
  2. NVDANVIDIA Corp
    3.2%$269.0MHistory
  3. MSFTMicrosoft Corp
    2.2%$190.0MHistory
  4. State Street Health Care Select Sector SPDR ETF81369Y209
    1.7%$144.5M
  5. BEBloom Energy Corp
    1.7%$143.8MHistory

Biggest buys

New and added positions, by estimated amount bought

  1. SPYSPDR S&P 500 ETF Trust
    +$164.0MAddedHistory
  2. State Street Health Care Select Sector SPDR ETF81369Y209
    +$144.5MNew
  3. BEBloom Energy Corp
    +$143.8MNewHistory
  4. MSFTMicrosoft Corp
    +$127.2MAddedHistory
  5. NVDANVIDIA Corp
    +$97.4MAddedHistory

Largest weight increases

New and added positions, by percentage points of the portfolio gained

  1. SPYSPDR S&P 500 ETF Trust
    +2.03 pp1.7% → 3.7%History
  2. State Street Health Care Select Sector SPDR ETF81369Y209
    +1.70 pp0.0% → 1.7%
  3. BEBloom Energy Corp
    +1.69 pp0.0% → 1.7%History
  4. MSFTMicrosoft Corp
    +1.44 pp0.8% → 2.2%History
  5. NVDANVIDIA Corp
    +1.26 pp1.9% → 3.2%History

Biggest sells

Reduced and sold-out positions, by estimated amount sold

  1. GLDSPDR Gold Trust
    −$182.3MReducedHistory
  2. iShares Tr464287234
    −$152.4MReduced
  3. GOOGLAlphabet Inc.
    −$152.0MReducedHistory
  4. MUMicron Technology Inc
    −$132.1MSold outHistory
  5. iShares Russell 2000 ETF464287655
    −$123.7MReduced

Largest weight decreases

Reduced and sold-out positions, by percentage points of the portfolio lost

  1. GLDSPDR Gold Trust
    −2.74 pp2.8% → 0.1%History
  2. MUMicron Technology Inc
    −1.68 pp1.7% → 0.0%History
  3. GOOGLAlphabet Inc.
    −1.55 pp1.6% → 0.1%History
  4. iShares Tr464287234
    −1.51 pp2.5% → 1.0%
  5. iShares Russell 2000 ETF464287655
    −1.27 pp1.6% → 0.3%

Metrics

13F metrics for Q2 2026, computed only from the numbers in the filings. Definitions below.

Portfolio value
$8.49B
+$647.3M (+8.3%) vs. prior quarter
Positions
1,417
+504 vs. prior quarter
Top 10 concentration
19.1%
Top 10 as share of value
Turnover
58.4%
Q2 2026, one quarter
Average holding period
2.7 quarters
Weighted by value

How these are calculated

  • Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
  • Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
  • Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
  • Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q4 2024), so positions held before then are understated.

13F filings by quarter

7 quarters, going back to Q4 2024. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.

Peak $10.2B (Q4 2025)

Q4 2024: $3.34BQ1 2025: $4.89BQ2 2025: $6.43BQ3 2025: $7.70BQ4 2025: $10.2BQ1 2026: $7.84BQ2 2026: $8.49B
Q4 2024Q2 2026
13F filings of Jain Global LLC by quarter
QuarterFiledPositionsValueTop 3 holdingsChangesFiling
Q2 2026Aug 14, 20261,417$8.49BSPYNVDAMSFTvs. Q1 2026SEC
Q1 2026May 15, 2026913$7.84BGLDiShares TrNVDAvs. Q4 2025SEC
Q4 2025Feb 17, 20261,053$10.2BiShares Core S&P 500 ETFSPYTSLAvs. Q3 2025SEC
Q3 2025Nov 14, 2025877$7.70BiShares Core S&P 500 ETFGLDTSLAvs. Q2 2025SEC
Q2 2025Aug 14, 20251,065$6.43BNVDATSLAAMTvs. Q1 2025SEC
Q1 2025May 15, 2025997$4.89BiShares Core S&P 500 ETFNVDAAPDvs. Q4 2024SEC
Q4 2024Feb 14, 2025715$3.34BiShares Core S&P 500 ETFAJGFDX–SEC

13D and 13G filings

Companies where Jain Global LLC reports owning 5% or more on Schedule 13D or 13G, and its latest filings.

Current stakes of 5% or more

2 companies, largest stake first.

Companies where Jain Global LLC owns 5% or more
CompanyLatest formStakeChangeFirst filedLatest filingFiling
VLOSVelos Acquisition I Corp.13G9.90%2.85M sharesNewMar 31, 20261 filingMar 31, 2026SEC
ONCH1RT Acquisition Corp.13G5.20%894.3K sharesNewNov 14, 20251 filingNov 14, 2025SEC

Latest filings

6 filings on file made by Jain Global LLC or listing it as a reporting person, newest first.

Schedule 13D and 13G filings by Jain Global LLC
CompanyFiled (ET)FormStakeChangeEvent dateFiling
DMRADamora Therapeutics, Inc.May 15, 20264:16 PM ET13G/A0.00%0 shares−7.50 ppfrom 7.50%Below 5%Mar 31, 2026SEC
VLOSVelos Acquisition I Corp.Mar 31, 20264:15 PM ET13G9.90%2.85M sharesNewMar 31, 2026SEC
DMRADamora Therapeutics, Inc.Feb 17, 20264:35 PM ET13G7.50%120.6K sharesNewDec 31, 2025SEC
ONCH1RT Acquisition Corp.Nov 14, 20254:19 PM ET13G5.20%894.3K sharesNewSep 30, 2025SEC
INRInfinity Natural Resources, Inc.Aug 14, 20254:02 PM ET13G/A3.00%450.4K shares−2.60 ppfrom 5.60%Below 5%Jun 30, 2025SEC
INRInfinity Natural Resources, Inc.Feb 10, 20255:00 PM ET13G5.60%744.4K sharesNewFeb 3, 2025SEC